Emory University | TB Preventive Treatment for People with HIV Shown Effective in Real-World Settings

7 September 2026

Emory University news release

TB is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable disease.

Although clinical trials have shown the benefit of TB preventive treatment in people with HIV, implementation in program settings was slow until a major commitment by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) in 2018. Since then, over 13 million people living with HIV worldwide have received TB preventive treatment.

A new study led by the Centers for Disease Control and Prevention’s Division of Global HIV and Tuberculosis and Emory University’s Rollins School of Public Health evaluated the real-world impact of TB preventive treatment in six countries with high TB and HIV rates (Haiti, Kenya, Nigeria, Uganda, Ukraine, and Zimbabwe). Findings were published in The Lancet HIV.

Read the full news release here.

Source: Emory University